CGM
The company said it plans to launch the latest model of its CGM in early 2023.
![[Left] Anjan Bhojarajan, HealthifyMe Chief Business Officer, and [Right] Tushar Vashisht, HealthifyMe CEO](/sites/mhn/files/styles/230x130/public/Anjan%2520%2526%2520Tushar-min.jpg?itok=FRkVznih)
It provides personalised nutrition and fitness strategies and smart nudges.
The continuous glucose monitoring system can be used to measure glucose levels in adults with diabetes for up to six months.
The company also unveiled its 2021 revenue.
This version of the Health2Sync app is currently available in Japan.
The funding will help the company grow its team and go through clinical trials.
The new system can be used with Apple iPhones and lets users check their glucose without needing a reader.
Metronom sees its "disruptive" technology pushing the advancement of digital diabetes management, providing patients with diabetes-related education, data analysis and other services.
In a J P. Morgan virtual talk, CEO Jason Gorevic said the programs have either already kicked off or will be launching later this year.
The announcement comes a few months after Medtronic acquired the InPen device's original maker, Companion Medical.